Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Beta-thalassemia surgery
Introduction
Overview
Overview
Surgical intervention is frequently required to guarantee optimum management of the accompanying morbidity in beta-thalassemia cases. The most prevalent types of surgical interventions associated with beta-thalassemia include splenectomy, cholecystectomy, leg ulcers, fractures, and extramedullary pseudotumor.
Surgery
Surgery
Surgical intervention is frequently required to guarantee optimum management of the accompanying morbidity in beta-thalassemia cases. Before undergoing surgical intervention, there are a few things of a more general nature that need to be taken into mind:
- Anemia
- Cardiovascular disease
- Thromboembolic events
- The consequences of iron overload
The most prevalent types of surgical interventions associated with beta-thalassemia include:
- Splenectomy: In severe cases with significant splenomegaly, splenectomy may be considered. This would help improve anemia and reduce transfusion requirements.
- Cholecystectomy: Recurrent gallstone due to chronic hemolysis.
- Leg ulcers
- Fractures
- Extramedullary pseudotumor[1][2][3].
References
References
- ↑ Saad GS, Musallam KM, Taher AT (June 2011). “The surgeon and the patient with β-thalassaemia intermedia”. Br J Surg. 98 (6): 751–60. doi:10.1002/bjs.7533. PMID 21480198.
- ↑ Ali S, Mumtaz S, Shakir HA, Khan M, Tahir HM, Mumtaz S, Mughal TA, Hassan A, Kazmi S, Sadia, Irfan M, Khan MA (December 2021). “Current status of beta-thalassemia and its treatment strategies”. Mol Genet Genomic Med. 9 (12): e1788. doi:10.1002/mgg3.1788. PMC 8683628 Check
|pmc=value (help). PMID 34738740 Check|pmid=value (help). Vancouver style error: initials (help) - ↑ Khandros E, Kwiatkowski JL (June 2019). “Beta Thalassemia: Monitoring and New Treatment Approaches”. Hematol Oncol Clin North Am. 33 (3): 339–353. doi:10.1016/j.hoc.2019.01.003. PMID 31030806.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2]